Advanz Pharma Corporation Ltd. (CXRXF)
Stock Price: $16.80 USD
0.00 (0.00%)
Updated May 4, 2021 12:19 PM EDT - Market closed
| Market Cap | 816.86M |
| Revenue (ttm) | 525.58M |
| Net Income (ttm) | n/a |
| Shares Out | 48.91M |
| EPS (ttm) | -1.53 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 4 |
| Last Price | $16.80 |
| Previous Close | $16.80 |
| Change ($) | 0.00 |
| Change (%) | 0.00% |
| Day's Open | 16.80 |
| Day's Range | 16.80 - 16.80 |
| Day's Volume | 63 |
| 52-Week Range | 2.13 - 17.20 |
News
There are no news available yet.
About CXRXF
ADVANZ PHARMA Corp. Limited, a pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products worldwide. The company operates through two segments: ADVANZ PHARMA International and ADVANZ PHARMA North America. Its ADVANZ PHARMA International segment offers a portfolio of branded and generic prescription products to wholesalers, distributors, hospitals, and pharmacies. This segment's products include Brinavess for the conversion of onset atrial fibrillation to sinus rhythm in adults; Ag... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | |
| CEO Graeme Neville Duncan | Country United Kingdom |
| Stock Exchange OTCMKTS | Ticker Symbol CXRXF |